1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. Japan >
  6. Daiichi Sankyo >
  7. M&A

Daiichi Sankyo Mergers & Acquisitions

Daiichi Sankyo M&A Summary

Daiichi Sankyo has acquired 4 companies. A total of 3 acquisitions came from private equity firms. It has also divested 4 assets.

Daiichi Sankyo’s largest acquisition to date was in 2008, when it acquired Ranbaxy Laboratories for $5.5B. It’s largest disclosed sale occurred in 2014, when it sold Ranbaxy Laboratories to Sun Pharmaceuticals Industries for $4.0B. Daiichi Sankyo has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity4
    • M&A Sell Activity4
  • Total Sectors Invested 1
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 6

Daiichi Sankyo

Daiichi Sankyo Co., Ltd.

3-5-1 Nihonbashi-Honcho Chuo-ku,
Tokyo, 103-8426
Japan,
+81 3 6225 1111
www.daiichisankyo.com

All (8) Buy (4) Sell (4)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2022-01-18 Daiichi Sankyo - Eight Branded Products · Life Science
Tokyo, Japan

Daiichi Sankyo - Eight Branded Products' provides sales and distribution rights in United States.

- Divestiture

Cosette Pharmaceuticals
Advisors: BofA Securities , Morgan Lewis

Daiichi Sankyo
Advisor: Goldman Sachs


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal